Marinus to price IPO of 4 million shares between 12.00 and $14.00

Stifel and JMP Securities to be joint bookrunning managers

By Devika Patel

Knoxville, Tenn., July 18 – Marinus Pharmaceuticals, Inc. will sell 4 million common shares in its initial public offering with a 30-day greenshoe option of 600,000 additional shares, according to a Form S-1/A filed Friday with the Securities and Exchange Commission. The deal was announced on May 12.

The shares will be sold at a price expected to fall between 12.00 and $14.00 per share.

Stifel and JMP Securities are the joint bookrunning managers. Oppenheimer & Co. and Janney Montgomery Scott are the co-managers.

Proceeds will be used for clinical trials, working capital and general corporate purposes.

The biopharmaceutical company is based in New Haven, Conn. The company intends to list its common stock on the Nasdaq under the symbol “MRNS.”

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.